The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis

Yazar: Deodhar, Atul, Bitman, Bojena, Yang, Yue, Collier, David H
Yayımlandı Clin Rheumatol (2016)

Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy

Yazar: Hobbs, Kathryn, Deodhar, Atul, Wang, Brian, Bitman, Bojena, Nussbaum, Joyce, Chung, James, Collier, David H
Yayımlandı Springerplus (2015)

Etanercept‐Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis

Yazar: Bonafede, Machaon, Johnson, Barbara H., Tang, Derek H., Shah, Neel, Harrison, David J., Collier, David H.
Yayımlandı Arthritis Care Res (Hoboken) (2015)

Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registry

Yazar: Mease, Philip J, Collier, David H, Saunders, Katherine C, Li, Guo, Kremer, Joel M, Greenberg, Jeffrey D
Yayımlandı RMD Open (2015)

Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis

Yazar: Sauer, Brian C., Chen, Wei, Xu, Yizhe, Shen, Jincheng, Accortt, Neil A., Collier, David H., Cannon, Grant W.
Yayımlandı Arthritis Res Ther (2020)

Defining and characterizing sustained remission in patients with rheumatoid arthritis

Yazar: Curtis, Jeffrey R., Trivedi, Mona, Haraoui, Boulos, Emery, Paul, Park, Grace S., Collier, David H., Aras, Girish A., Chung, James
Yayımlandı Clin Rheumatol (2017)

Increased Expression of Growth Differentiation Factor-15 in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

Yazar: Meadows, Christina A., Risbano, Michael G., Zhang, Li, Geraci, Mark W., Tuder, Rubin M., Collier, David H., Bull, Todd M.
Baskı/Yayın Bilgisi 2011

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial

Yazar: Mease, Philip J., Gladman, Dafna D., Collier, David H., Ritchlin, Christopher T., Helliwell, Philip S., Liu, Lyrica, Kricorian, Gregory, Chung, James B.
Yayımlandı Arthritis Rheumatol (2019)

Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritis

Yazar: Reed, George W., Collier, David H., Koenig, Andrew S., Saunders, Katherine C., Pappas, Dimitrios A., Litman, Heather J., Kremer, Joel M., Kotak, Sameer
Yayımlandı Arthritis Res Ther (2017)

Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination

Yazar: Strand, Vibeke, Mease, Philip J, Maksabedian Hernandez, Ervant J, Stolshek, Bradley S, Liu, Lyrica X H, Collier, David H, Kricorian, Gregory, Merola, Joseph F
Yayımlandı RMD Open (2021)

Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)

Yazar: Mease, Philip J, Gladman, Dafna D, Samad, Ahmed S, Coates, Laura C, Liu, Lyrica X H, Aras, Girish A, Collier, David H, Chung, James B
Yayımlandı RMD Open (2018)

Tumour necrosis factor inhibitor exposure and radiographic outcomes in Veterans with rheumatoid arthritis: a longitudinal cohort study

Yazar: Cannon, Grant W, Erickson, Alan R, Teng, Chia-Chen, Huynh, Tina, Austin, Sharon, Wade, Sally W, Stolshek, Bradley S, Collier, David H, Mutebi, Alex, Sauer, Brian C
Yayımlandı Rheumatol Adv Pract (2019)

Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis

Yazar: Cannon, Grant W., DuVall, Scott L., Haroldsen, Candace L., Caplan, Liron, Curtis, Jeffrey R., Michaud, Kaleb, Mikuls, Ted R., Reimold, Andreas, Collier, David H., Joseph, George J., Harrison, David J., Sauer, Brian C.
Yayımlandı Adv Ther (2016)

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis

Yazar: Coates, Laura C, Merola, Joseph F, Mease, Philip J, Ogdie, Alexis, Gladman, Dafna D, Strand, Vibeke, van Mens, Leonieke J J, Liu, Lyrica, Yen, Priscilla K, Collier, David H, Kricorian, Gregory, Chung, James B, Helliwell, Philip S
Yayımlandı Rheumatology (Oxford) (2020)

Items for developing revised classification criteria in systemic sclerosis: results of a consensus exercise with the ACR/EULAR working committee for classification criteria in syst...

Yazar: Fransen, Jaap, Johnson, Sindhu R, van den Hoogen, Frank, Baron, Murray, Allanore, Yannick, Carreira, Patricia E, Czirják, László, Denton, Christopher P, Distler, Oliver, Furst, Daniel E, Gabrielli, Armando, Herrick, Ariane, Inanc, Murat, Kahaleh, Bashar, Kowal-Bielecka, Otylia, Medsger, Thomas A, Mueller-Ladner, Ulf, Riemekasten, Gabriela, Sierakowski, Stanislaw, Valentini, Gabriele, Veale, Doug, Vonk, Madelon C, Walker, Ulrich, Chung, Lorinda, Clements, Philip J., Collier, David H, Csuka, Mary E, Jimenez, Sergio, Merkel, Peter A, Seibold, James R, Silver, Richard, Steen, Virginia, Tyndall, Alan, Matucci-Cerinic, Marco, Pope, Janet E, Khanna, Dinesh
Baskı/Yayın Bilgisi 2012